INmune Bio Inc.
NASDAQINMB heads into its May 7 earnings with one of the most aggressive short positions in the biotech universe — and a stock price that has quietly been rallying against it. Short sellers have dug in with real conviction. SI % of free float is running near 15%, a level that ranks in the 4th percentile of all stocks on the ORTEX universe — meaning almost no other name carries a heavier…
Snapshot as of 6 May 2026
INMB heads into its May 7 earnings with one of the most aggressive short positions in the biotech universe — and a stock price that has quietly been rallying against it. Short sellers have dug in with real conviction.…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for INMB — free to start on ORTEX.
Sign up for free →Open INMB on ORTEX